Attendee search 

Kymab is a biopharmaceutical company engaged in the discovery and development of human monoclonal antibody therapeutics.

ReNeuron is a leading, clinical-stage stem cell business. Its primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.